MedTrace Logo

Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantitis: A Randomized Clinical Trial

NCT07644975 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-06-12

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether adjunctive electrolytic surface decontamination can improve the outcomes of surgical treatment of peri-implantitis. The main questions it aims to answer are:

* Does electrolytic surface decontamination reduce probing pocket depth more effectively than conventional surgical treatment alone?
* Does electrolytic surface decontamination improve bleeding on probing, suppuration, and radiographic bone levels?

Researchers will compare conventional surgical treatment plus electrolytic surface decontamination with conventional surgical treatment alone.

Participants will:

* Receive surgical treatment for peri-implantitis
* Be randomly assigned to one of the two treatment groups
* Attend follow-up visits for clinical and radiographic examinations
* Undergo assessment of probing pocket depth, bleeding on probing, suppuration, and bone level changes during follow-up

Conditions

  • Peri-implantitis

Interventions

PROCEDURE

Electrolytic Surface Decontamination

Electrolytic implant surface decontamination performed using the GalvoSurge system as an adjunct to conventional surgical treatment. The procedure is intended to remove biofilm and contaminants from the implant surface through an electrolytic cleaning process.

PROCEDURE

Conventional Surgical Treatment

Conventional surgical treatment of peri-implantitis consisting of flap elevation, mechanical implant surface decontamination using a titanium brush, and hydrogen peroxide application according to the study protocol.

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Volkan Arısan, Professor · Istanbul University Faculty of Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2029-08-01
Completion
2029-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07644975 on ClinicalTrials.gov